Article Listing - US Rx drug market in relative decline

NEW PRES AT PROCORDIA

6 April 1992

Jan Ekberg has been named as president and chief executive at Procordia, in succession to Soren Gyll who has become...

ARIAD PHARMACEUTICALS STOCK SALE

6 April 1992

The biotechnology concern Ariad Pharmaceuticals of the USA is reported to have raised $46 million in a private stock sale,...

CHIROS ACQUIRES ENZYMATIX' CHIRAL DIV

6 April 1992

A new UK company, Chiros Ltd, was formed last month to purchase the assets and business of the Chiral division...

US PHARMACY COMPOUNDING GUIDE

6 April 1992

The US Food and Drug Administration has, for the first time, issued a pharmacist compounding compliance guide, due to the...

MAINTENANCE ULCER THERAPY CUT URGED

6 April 1992

A team of UK gastroenterologists have called for physicians to stop treating duodenal ulcer patients with maintenance H2 antagonist therapy....

ROMANIAN HEALTH SECTOR PLANS

6 April 1992

Romania's Minister of Health, Mircea Aiorescu, has announced in Bucharest that his Ministry is planning to change various aspects of...

SIEMENS IN ALBANIA

30 March 1992

Siemens of Germany will play an increasingly important role in the development of medicines in Albania, reports the Albanian Telegraphic...

NEW PHARMA PLANT FOR YUGOSLAVIA

23 March 1992

A new pharmaceutical plant is to be constructed in Vrsac in the Yugoslav province of Vojvodina as part of the...

BOEH INGELHEIM CHF DRUG DISCONTINUED

23 March 1992

Boehringer Ingelheim has discontinued development of pimobendan, a compound previously under investigation as a treatment for heart failure. The announcement...

SECOND EUROPLANT FOR UPJOHN

23 March 1992

US pharmaceuticals major Upjohn is to open a second plant in Europe with a capacity of bet-ween 7,000 and 10,000...

Showing 94541-94550 of 95353 articles